0
Your cart
Your cart is empty
Anti-Amyloid-Beta 1-11, Rabbit, Polyclonal

Anti-Amyloid-Beta 1-11, Rabbit, Polyclonal

$352
Pan-antibody for Amyloid-Beta. This antibody displays high affinity for monomers, oligomers and fibrils derived from Amyloid-Beta 1-40 and 1-42.
Read more...

    Description

    Article no.: AS19 4309

    Product Information

    Immunogen

    Synthetic peptide chosen from human Abeta (1-11) peptide. Amino acid sequence:
    DAEFRHDSGYE

    Host

    Rabbit

    Clonality

    Polyclonal

    Purity

    Affinity purified

    Format

    Lyophilized

    Quantity

    50 µg

    Reconstitution

    Add 50 ul sterile water to reconstitute to 1 mg/ml

    Storage


    Store lyophilized/reconstituted at -20°C; once reconstituted make aliquots to avoid repeated freeze-thaw cycles. Please, remember to spin tubes briefly prior to opening them to avoid any losses that might occur from lyophilized material adhering to the cap or sides of the tubes.

    Tested applications

    Dot Blot (Dot), ELISA (ELISA)

    Recommended Dilution

    1 : 1000 (DB), 1 : 3000 (ELISA)

    Expected | apparent MW

    4.5 kDa


    Reactivity

    Confirmed Reactivity

    Human

    Predicted Reactivity

    Bovine, Chicken, Dog, Porcine, Rabbit

    Not reactive in

    No confirmed exceptions from predicted reactivity are currently known.


    Application Examples

    Application examples















    Dot blot and Western analysis

    • Membrane: Nitrocellulose
    • Blocking buffer: 1% dry milk in PBS, 0.3% Tween 20
    • Antibody dilution : 1:1000
    • Secondary antibody: anti-rabbit (HRP)
    • Detection: Enhanced Chemoluminescence (pico) 300s
                            

    Additional Information

    Additional information

    The antibody display high affinity for monomers, oligomers and fibrils derived from Amyloid-Beta 1-40 and 1-42.


    Related Products

    Related products

    Available antibodies for Alzheimer's disease


    Background

    Background


    Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the growing population of elderly people. A hallmark of AD is the accumulation of plaques in the brain of AD patients. The plaques predominantly consist of aggregates of amyloid-beta (Abeta), a peptide of 39-42 amino acids generated in vivo by specific, proteolytic cleavage of  the amyloid precursor protein.